A former Nuix director has made a bid to stay a shareholder class action, which accuses the software company of failing to alert the market to red flags in the business, pending the outcome of separate proceedings by ASIC.
The ACCC’s rejection of a regional network arrangement between Telstra and TPG was “confusing” and the telecos might be free to vary the transaction, says a judge who is overseeing a challenge to the competition regulator’s decision.
Former president of the Melbourne Football Club and Clayton Utz veteran Glen Bartlett has lost a bid to keep his defamation case against four MFC board members in Western Australia, with a judge finding the “relevant characters overwhelmingly continue to live in Melbourne.”
Hitting back at ASIC’s claims it misled investors and breached disclosure rules, technology company Nuix says it had no knowledge it was failing to meet its FY21 forecast and didn’t need to disclose to investors draft documents showing missed internal targets.
The man behind the Twitter handle Stock Swami has been ordered to pay $275,000 in damages to Tolga Kumova, after a judge found his tweets defamed the mining investor by accusing him of insider trading, misleading the market, and running a pump and dump scheme.
Class action settlement sums reached new highs last year, with the ten largest agreements totalling almost $1 billion, almost half of which was secured by one plaintiff law firm.
Westpac has agreed to pay $29.95 million to settle a class action alleging subsidiaries BT Funds Management Limited and Westpac Life Insurance Services Limited charged customers excessive superannuation fees between 2007 and 2019.
Gaming company Konami will cough up $35.9 million dollars to rival company Aristocrat Technologies next year, eight years after a judge found that it had violated Aristocrat’s patent for a slot machine with an improved jackpot feature.
Gaming company Konami Australia has been ordered to pay rival Aristocrat Technologies a proportion of profits from the sale of patent-infringing poker machines over a 12-year period, as well as a chunk of damages for supply of the games that generated no revenue at all.
A contradictor has argued that the High Court must consider the reputation of Botox maker Allergan’s trade marks in a cosmetic company’s challenge to a judgment finding it infringed the marks by marketing its topical creams as Botox alternatives.